In this edition:
- Phylogica launches a new disruptive technology: the Endosome Escape Trap
- Janssen expansion driven by delivery on goals of CPP discovery project
- Appointment of Dr Richard Hopkins as CEO
- Management changes extend cash runway while maintaining focus on delivery
- Maintaining focus on Phylogica’s business development activities
- New patents strengthen Phylogica’s IP estate
- Grant to fund biosensor development collaboration with University of Queensland
- Recent antimicrobials deal with Cubist Pharmaceuticals
To view Newsletter please download PDF below:
